Meeder Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Meeder Advisory Services's VRTX Position: Q1 2026 in Review

Meeder Advisory Services increased its Vertex Pharmaceuticals (VRTX) stake by 2.2% in Q1 2026, buying an estimated $61.6K and bringing the position to 6,197 shares worth $2.77M. The position accounts for 0.12% of the portfolio, ranked #123.

Meeder Advisory Services first reported a position in VRTX in Q4 2022 and has held it in 14 quarters since. The position peaked at $3.08M in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

• Meeder Advisory Services held 6,197 shares of Vertex Pharmaceuticals worth $2.77M as of Q1 2026.
• Meeder Advisory Services bought 132 Vertex Pharmaceuticals shares in Q1 2026, an estimated $61.6K.
• Vertex Pharmaceuticals made up 0.12% of Meeder Advisory Services's portfolio in Q1 2026, its #123 holding.
• Meeder Advisory Services first reported a position in Vertex Pharmaceuticals in Q4 2022 and has held it in 14 quarters since.
• Meeder Advisory Services's Vertex Pharmaceuticals position peaked at $3.08M in Q1 2025.
• 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Meeder Advisory Services's 13F filing for Q1 2026, filed 7 May 2026.